Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001278819-06-000012
Filing Date
2006-05-16
Accepted
2006-05-16 16:12:25
Documents
1
Period of Report
2006-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6159
  Complete submission text file 0001278819-06-000012.txt   8159
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11 BELLINGHAM ROAD CHESTNUT HILL MA 02467-3229
Business Address
CASTALDI DAVID L (Reporting) CIK: 0001234809 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 06845988